Pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) are produced in large quantities locally in the joints and subsequently enter the bloodstream. TNF-α and IL-6 may promote LDL metabolism by ...

High cholesterol doesn’t announce itself. No pain. No fever. No bad days that force you to stop and think. And that’s exactly why it’s dangerous. You .

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children. This recommendation statement was first published in ...

Researchers have developed a new compound, ZTA-261, that binds to thyroid hormone receptor beta (THR ). THR plays an important role in the regulation of lipid metabolism, which affects lipid levels in ...

Hyperlipidemia is a risk factor for stroke and CAD. Neuroscience nurses play a key role in diagnosis and treatment of hyperlipidemia for patients at risk of stroke by promoting accurate blood sampling ...

Please provide your email address to receive an email when new articles are posted on . The FDA extended its approval of alirocumab to treat a genetic lipid disorder in patients as young as 8 years.

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

The practice of lipid screening in children still hasn't taken off despite guideline recommendations to do so as early as age 9 years, according to a large cross-sectional study. U.S. records show ...

Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone ...